EXFY News and Press, Expensify Inc. From 11/17/23

2023-11-17 10:26:04 ET More on Expensify Expensify stock drops 25% after Q3 earnings miss Expensify stock dips as J.P. Morgan starts at Underweight For further details see: Expensify says director Christen bought 47.05K class A common shares in co

2023-11-15 17:30:35 ET Gainers Veeco Instruments  ( VECO ) +5% . Humacyte ( HUMA ) +5% . Expensify ( EXFY ) +5% . ContextLogic ( WISH ) +4% . Tetra Tech ( TTEK ) +4% . Losers: Cisco Systems ( CSCO ) -11% . ...

2023-11-08 22:53:02 ET Expensify, Inc. (EXFY) Q3 2023 Earnings Conference Call November 7, 2023 5:00 PM ET Company Participants Ryan Schaffer - CFO Anu Muralidharan - COO Conference Call Participants Steve Enders - Citigroup Inc. Aaron Kimson - JMP Se...

2023-11-08 13:40:12 ET Gainers: Tenon Medical ( TNON ) +37% . Blade Air Mobility ( BLDE ) +32% . Novo Integrated Sciences ( NVOS ) +29%. Therealreal ( REAL ) +27% . ShiftPixy ( PIXY ) +20% . American Public Education ( APEI )...

2023-11-08 09:14:25 ET More on Expensify Expensify reports Q3 results Expensify: A Wait-And-See Approach Is Appropriate Expensify stock dips as J.P. Morgan starts at Underweight For further details see: Expensify stock drops 25% after Q3 earnings miss

2023-11-07 16:08:27 ET Expensify press release ( NASDAQ: EXFY ): Q3 GAAP EPS of -$0.21 misses by $0.09 . Revenue of $36.5M (-14.1% Y/Y) misses by $2.65M . For further details see: Expensify GAAP EPS of -$0.21 misses by $0.09, revenue of $36.5M misses by $...

Interchange derived from the Expensify Card grew to $3.1 million, an increase of 65% as compared to the same period last year. Expensify, Inc. (Nasdaq: EXFY), a payments superapp that helps individuals and businesses around the world simplify the way they manage money across expenses, c...

Weyco Group Inc. (WEYS) is expected to report for Q1 2024 Gladstone Land Corporation (LAND) is expected to report $0.16 for Q3 2023 PlayAGS Inc. (AGS) is expected to report $0.01 for Q3 2023 Ardmore Shipping Corporation (ASC) is expected to report $0.43 for Q3 2023 Sage Therapeuti...

Expensify Inc. (EXFY) is expected to report $-0.09 for Q3 2023

2023-10-31 17:24:37 ET Gainers: Freshworks (FRSH) +5% . Verve Therapeutics ( VERV ) +3% . Expensify ( EXFY ) +3% . REGENXBIO ( RGNX ) +3% . ACI Worldwide ( ACIW ) +3% . Losers: Big 5 Sporting Goods ( BGFV ) -11% . ...